This Thesis describes work on the metabolism of
salicylazosulphapyridine in normal volunteers and in
patients with ulcerative colitis or Crohn's disease.
The effect of coincidental administration of iron and
calcium in healthy volunteers on the absorption of
sulphasalazine and its metabolites has been investi¬
gated. In patients with ulcerative colitis or Crohn's
disease an attempt has been made to correlate the clinical
state of the disease and the serum concentration of
sulphasalazine or its metabolites. The relationship
of the toxic effects due to sulphasalazine with the
acetylator phenotype, dosage and serum concentration
of the drug and its metabolites has also been explored.
The feasibility of reintroducing the drug in patients
with side effects has been studied. The metabolism
of sulphasalazine in patients with ileostomy or colostomy
was investigated